Yan Leyfman?linkedIn
Oct 19, 2025, 11:19
Yan Leyfman: Insightful Strategies Advancing the Safety and Precision of Myeloma Care
Yan Leyfman, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Exceptional presentation by global multiple myeloma cell therapy leader Dr. Adriana Rossi (Icahn School of Medicine at Mount Sinai) on managing T-cell–directed toxicities at the 2025 Lymphoma, Leukemia & Myeloma Congress!
Insightful strategies advancing the safety and precision of myeloma care.”

Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
